Yixiang Li

Title: **Yixiang Li: Innovator in Plasmofluidic Technology**

Introduction

Yixiang Li is a notable inventor based in Santa Cruz, California. With a portfolio of three patents, he has significantly contributed to the field of optofluidics and microfluidic technology, focusing on the isolation and manipulation of bioparticles in innovative ways.

Latest Patents

Among his latest patents is the invention of **Plasmofluidic Microlenses for Label-Free Optical Sorting of Bioparticles**. This groundbreaking optofluidic device features a housing with an inlet port for fluid containing bioparticles and an outlet port for the processed fluid. It houses a microlens that facilitates the flow of particles and includes a light source for enhanced optical manipulation.

Another significant patent is his work on **Microfluidic Acoustic Devices and Methods**. This patent describes techniques, devices, and systems aimed at isolating target particles from samples, enabling efficient affinity-based isolation by utilizing microfluidic channels to direct particles to capture agents.

Career Highlights

Yixiang Li has established himself as a key figure at the University of California, where he employs his expertise in material science and engineering to innovate in microfluidic applications. His patents reflect his commitment to advancing technology that can streamline bioparticle sorting processes, which is critical in biomedical applications.

Collaborations

Throughout his career, Yixiang has collaborated with distinguished colleagues, including Ahmet Ali Yanik and Xiangchao Zhu. These partnerships have fostered dynamic research environments, leading to the development of pioneering technologies and methods in the realm of fluidic devices.

Conclusion

Yixiang Li exemplifies the spirit of innovation in science and engineering. His contributions to the fields of plasmofluidics and microfluidics not only demonstrate his ingenuity but also address important challenges in biological particle manipulation. With a strong foundation in research and a commitment to collaboration, Li continues to pave the way for advancements that could revolutionize the handling of bioparticles in various applications.